Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$5.45 - $7.35 $8,175 - $11,025
-1,500 Reduced 0.59%
253,069 $1.86 Million
Q3 2022

Nov 14, 2022

SELL
$6.89 - $9.39 $2.23 Million - $3.04 Million
-323,691 Reduced 55.98%
254,569 $1.83 Million
Q2 2022

Aug 15, 2022

SELL
$6.71 - $9.52 $3.06 Million - $4.34 Million
-455,962 Reduced 44.09%
578,260 $4.92 Million
Q1 2022

May 16, 2022

SELL
$6.41 - $13.89 $871,695 - $1.89 Million
-135,990 Reduced 11.62%
1,034,222 $9.28 Million
Q4 2021

Feb 18, 2022

BUY
$10.41 - $13.95 $12.2 Million - $16.3 Million
1,170,212 New
1,170,212 $16.2 Million

Others Institutions Holding ALPN

About ALPINE IMMUNE SCIENCES, INC.


  • Ticker ALPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,006,700
  • Description
  • Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...
More about ALPN
Track This Portfolio

Track Tcg Crossover Management, LLC Portfolio

Follow Tcg Crossover Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcg Crossover Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tcg Crossover Management, LLC with notifications on news.